基于 1 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Explore the detailed record of transactions filed by Lucas Brent T.. Officer active across 1 company, notably Envoy Medical, Inc.. Cumulatively, 6 filings have been published. Split: 2 buys · 0 sell. Total volume traded: €30k. Activity tracked since 21 November 2023. The latest transaction was disclosed on 29 May 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Lucas Brent T. is Chief Executive Officer at Envoy Medical, Inc. (XNAS). He has 6 filings in total, and across the 6 recent filings considered, purchases total EUR 30004 and sales total EUR 0, with activity from 2023-11-24 to 2026-06-04; the modal transaction nature is listed as Attribution.